Artificial organ and bionics market seen reaching $63.1 billion by 2030

The artificial organ and bionics market is projected to grow from $35.86 billion in 2025 to $63.1 billion by 2030, driven by donor organ shortages, biomedical engineering advances and rising demand for bionic systems. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The artificial organ and bionics market is expanding as hospitals and patients look for ways to replace or support failing organs. - The sector’s growth reflects a larger shift toward long-term organ replacement, bionic mobility and brain-computer interface technologies. - The market’s projected rise to $63.1 billion by 2030 signals sustained investment across medical devices, implants and rehabilitation technologies.

What happened: - The Business Research Company published a market outlook on the artificial organ and bionics sector on July 27, 2026. - The report estimates the market will grow from $35.86 billion in 2025 to $40.03 billion in 2026. - The forecast implies an 11.6% compound annual growth rate in 2026. - The market is projected to reach $63.1 billion by 2030, with a 12.1% compound annual growth rate over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also offered a free sample of the report and a full market report.

The details: - Artificial organs and bionics are devices or machines designed to substitute for damaged or missing body organs. - Bionics refers to artificial systems that replicate certain characteristics of living organisms. - The core goal of these technologies is to extend life and improve quality of life when organs fail or are lost. - Growth has been driven by shortages of donor organs, advances in biomedical engineering, wider use of prosthetics, improved survival rates for chronic illnesses and better surgical implantation techniques. - Future growth is tied to investment in biohybrid organ research, demand for smart bionic systems, broader use of brain-computer interfaces, a focus on quality of life and convergence across organ replacement therapies. - Trends highlighted in the report include more advanced artificial organs, wider adoption of bionic limbs and exoskeletons, neural interface integration, growth in implantable life-support devices and more emphasis on long-term organ replacement solutions. - The report says global organ transplants are helping drive demand for artificial organ and bionic technologies. - The Organ Procurement and Transplantation Network reported 48,149 organ transplants in the United States in 2024, a 3.3% increase from the prior year. - Of those US transplants, 41,119 came from deceased donors and 7,030 came from living donors.

Between the lines: - The forecast suggests the market is moving from early adoption toward broader clinical use and commercialization. - The combination of donor shortages and technical progress points to artificial organs and bionics as a complement to, not just a substitute for, traditional transplantation. - Regional leadership by North America and faster growth in Asia-Pacific suggests both mature demand and expanding adoption in emerging health care markets.

What's next: - The report expects continued growth through 2030 as smart bionics, neural interfaces and implantable support systems mature. - Market research tools in the company’s 2026 reports will include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspots infographics and updated graphics and tables. - The company invited prospective readers to contact Saumya Sahay for more information.

The bottom line: - Artificial organs and bionics are moving from niche medical solutions toward a larger global market, with demand supported by transplant needs and faster-moving device innovation.